Leadership teams from industry giants met with IT and Industries Minister K.T. Rama Rao in Washington and New York. The discussions revolved around investment opportunities, expansion plans if any and other aspects to prosper.
Meeting with Lockheed Martin
IT and Industries Minister K.T. Rama Rao had a meeting with ‘Lockheed Martin Corporation’ senior leaders; Ray Piselli, VP International Business and Global Business Development and Dave Sutton, Director for International Government Affairs on ongoing manufacturing programmes in Hyderabad and new programmes in pipeline.
During the meeting, held in Washington DC, the Lockheed Martin leaders appreciated the unmatched support received from Telangana Government during the pandemic days and assured support for the various skilling initiatives undertaken by the State including the plan to establish a world class Aerospace university proposed in partnership with leading OEMS.
The Lockheed Martin Corporation is an American aerospace, arms, defense, information security, and technology corporation.
“Glad to note that Lockheed is planning their next supply chain meet in Hyderabad and is actively speaking to several Telangana based MSMEs and start-ups for fruitful collaborations,” said KTR.
Principal Secretary of IT and Industries Departments, Jayesh Ranjan, Special Secretary, Investment Promotion & NRI Affairs, E Vishnu Vardhan Reddy, Director, Aerospace & Defence, Praveen PA were present at the meetings.
Meeting with General Atomics
IT and Industries Minister K.T. Rama Rao met Mr Vivek Lall, CEO, General Atomics (GA) and explored the possibilities for Manufacturing, MRO and R&D collaborations for their military and nuclear systems.
Minister KTR invited General Atomics to consider manufacturing their drones in Hyderabad and join hands in the skilling partnerships and Aerospace University project proposed by the Telangana State Government.
General Atomics, an American energy and defense corporation founded in 1955, produces high tech predator drones, a series of unmanned aircraft and provides electro-optical, radar, signals intelligence, and automated airborne surveillance systems.
Meeting with Consul General of India in New York
Before moving to Washington DC, the Minister had a fruitful meeting with Mr. Randhir Jaiswal, Consul General of India in New York. Prospective business opportunities, possible areas of collaboration like innovation were among a host of topics discussed in the meeting.
During the meeting, KTR highlighted Telangana as an ideal investment choice, with a focus on a favorable and inclusive environment for investors. Telangana’s innovation ecosystem, comprising research organizations, educational institutions, startups, and renowned companies, positions it as a leading investment destination.
Principal Secretary of IT and Industries Departments, Jayesh Ranjan, Special Secretary, Investment Promotion & NRI Affairs, E Vishnu Vardhan Reddy were present at the meeting.
Omnicom Group Inc.,
The leadership team of Omnicom Group Inc., an American global media, marketing and corporate communications holding company, headquartered in New York City met Minister K.T. Rama Rao in New York. Potential collaboration opportunities were discussed during the meeting.
GeneSys Biologics Pvt Ltd
IT and Industries Minister KTR met Civica and GeneSys leadership, including Mr. Tom Damratoski, Sr. Vice President, Biologics, Civica, and Mr. Allan Coukell, Sr. Vice President, Public Policy, Civica & President, Civica Foundation, as well as Mr. Venkat Reddy Yelma, Director, and Mr. Roopesh Kondrella, Director, from GeneSys Biologics.
Minister KTR expressed delight in learning that GeneSys, which has already invested approximately $50 million in Genome Valley, Hyderabad, has plans to invest an additional $50-60 million in setting up a new large scale recombinant bulk manufacturing facility (from fermentation to purified bulk insulin) for its insulin analogues.
“I am delighted to note the expansion plans of GeneSys Biologics Pvt Ltd for Genome Valley which will not only contribute to the growth of Hyderabad’s biotech sector but also facilitate their ongoing collaboration with US-based Civica Rx. I would like to congratulate both companies as their efforts will contribute to addressing the Insulin affordability crisis and improve the lives of patients living with diabetes,” said KTR.
GeneSys, a science-based biopharmaceutical company headquartered in Hyderabad, Telangana State, is focused on developing and manufacturing high-quality, affordable medications, including multiple insulin analog biosimilars. GeneSys currently employs about 250 personnel and anticipates adding approximately 300 jobs for its new facility.
